Search

Search Results

• 

  Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity

  Y. Emad, T. Gheita, H. Darweesh, P. Klooster, R. Gamal, H. Fathi, N. El-Shaarawy, M. Gamil, M. Hawass, R.M. El-Refai, H. Al-Hanafi, S. Abd-Ellatif, A. Ismail, J. Rasker

  85-91

  06-07-2018

  Published: 6 July 2018

  2515

  PDF: 1258
• 

  Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre

  A. Bortoluzzi, M. Padovan, I. Farina, E. Galuppi, F. De Leonardis, M. Govoni

  350-359

  20-12-2012

  Published: 20 December 2012

  3013

  PDF: 2598
• 

  Urinary CXCL10: a marker of nephritis in lupus patients

  M. A. Marie, R. E. Abu Khalil, H. M. Habib

  292-297

  17-03-2014

  Published: 17 March 2014

  2836

  PDF: 1631
• 

  The association between serum prolactin levels and interleukin-6 and systemic lupus erythematosus activity

  W.A. Wan Asyraf, M.S. Mohd Shahrir, W. Asrul, A.W. Norasyikin, O. Hanita, W.Y. Kong, M.T. Azmi

  241-250

  20-12-2018

  Published: 20 December 2018

  1570

  PDF: 941

• BAFF/APRIL pathway in Sjögren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity

  M. Vadacca, D. Margiotta, D. Sambataro, F. Buzzulini, M. Lo Vullo, A. Rigon, A. Afeltra

  259-265

  Published:

  1849

  PDF: 2037